Schedule 13G ownership disclosure

Amneal Pharmaceuticals Inc

Common Stock · CUSIP: 03168L105

Event date: 2025-03-31

Filing-level shares
15,762,727
Percent of class
5.02%
  • The Vanguard Group

    Shares: 15,762,727 · Class: 5.02%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000932471-25-000656
Form type
SCHEDULE 13G
Filer
Amneal Pharmaceuticals, Inc.
CIK
CIK 1723128
Filed
Apr 30, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub